Pharming, Transmedic sales and marketing update

Pharming granted Transmedic commercialization rights to Ruconest conestat alfa in Brunei, Indonesia, Malaysia, the Philippines, Singapore and Thailand to treat acute attacks of hereditary angioedema (HAE). Transmedic will be responsible for regulatory approvals and will purchase Ruconest from Pharming at an undisclosed fixed transfer price. Details were not disclosed. ...